Background. Globally, family planning services are being strengthened and the range of contraceptive choices expanded. Data on contraceptive coverage and service gaps could help to shape these initiatives. Objective. To assess contraception coverage in South Africa (SA) and identify underserved populations and aspects of programming that require strengthening. Methods. Data from a 2012 SA household survey assessed contraception coverage among 6 296 women aged 15 -49 years and identified underserved populations. Results. Two-thirds had an unintended pregnancy in the past 5 years, a quarter of which were contraceptive failures. Most knew of injectable (92.0%) and oral contraception (89.9%), but fewer of intrauterine devices (56.1%) and emergency contraception (47.3%). Contraceptive prevalence was 49.1%, and 41.8% women used modern non-barrier methods. About half had ever used injectable contraception. Contraception was lower in black Africans and younger women, who used a limited range of methods. Conclusion. Contraception coverage is higher than many previous estimates. Rates of unintended pregnancy, contraceptive failure and knowledge gaps, however, demonstrate high levels of unmet need, especially among black Africans and young women.
RESEARCH
Contraception has profound benefits for women and society, including reduced maternal and infant mortality and morbidity, empowerment of women to make informed choices about fertility, economic advancement, and a reduction in the number of children infected with HIV. [1, 2] In recent decades, contraceptive use has risen markedly worldwide, although at a much slower pace in sub-Saharan Africa than elsewhere. [3] About a quarter of women in sub-Saharan Africa currently use modern contraceptive methods, with levels highest in southern Africa. [4, 5] In South Africa (SA), for example, estimates of the proportion of women of reproductive age who are protected against unplanned pregnancies, using modern contraceptive methods, have increased steadily from 26.3% in 2002/2003 to 37.3% in 2013/2014. [6] These figures are drawn from a district health information system covering the public sector, while population level end-user data have yielded somewhat different estimates. For example, the 2003 Demographic and Health Survey, [7] the most recent available national report, found a contraceptive prevalence of 64.7%, similar to more recent modelling estimates. [8] Regardless of which figures are correct, the continued rise in the number of terminations of pregnancy in SA among all age groups suggests that substantial deficiencies remain in accessing family planning services. [6] Increasing the range of contraception choices available is a key component of ensuring access for women, their partners and couples to the most effective method they wish to use. Global policymakers and policy advocates have placed particular emphasis on increasing access to long-acting reversible contraception (LARC) methods, including intrauterine devices and subdermal implants. These are highly effective, and markedly diminish the need for user adherence and contact with health workers. Many providers in SA are, however, still unfamiliar with these methods. [9] [10] [11] In SA, as throughout subSaharan Africa, the injectable progestins depot-medroxyprogesterone acetate (DMPA) and norethisterone enanthate (NET-EN) are the most popular contraceptive methods, [4] and their use has continued to rise over time. [12] Nationally, about 5.8 million doses of DMPA are administered annually. [6] By contrast, in most high-income countries, use of injectable contraceptives is rare, aside from in marginalised groups, such as poor, African American or aboriginal women. [13] [14] [15] [16] The popularity of injectables in sub-Saharan Africa is ascribed to its convenience for providers and women, cost effectiveness, and high acceptability among women and health providers. [2] Method discontinuation and contraceptive failure, however, frequently occur with this method. [17, 18] Using data from the 2012 SA National HIV Prevalence, Incidence and Behaviour Survey, [19] this analysis assesses the extent of unmet contraceptive need, and estimates the overall contraception coverage and methods used. We also aimed to identify underserved populations through examining the demographic factors and sexual behaviours RESEARCH associated with contraceptive use. In addition to providing updated figures on key family planning indicators, the study seeks to identify the areas that need to be addressed to strengthen family planning services in SA and similar settings.
Methods

Survey sampling, field and laboratory procedures
The fourth SA National HIV Prevalence, Incidence and Behaviour Survey [19] took place from January to November 2012. This population-based survey applied multistage stratified sampling by province; locality (urban formal, urban informal, rural formal including commercial farms, and rural informal or tribal authority areas); and predominant racial groups. Sampling frames were based on enumerator areas (EA) used in the national census, updated in 2007 to reflect changes in the sociodemographic profile of the country since 2001. In total, 1 000 EAs were selected from a database of 86 000 EAs as the primary sampling units, 15 households within each EA constituted the secondary sampling unit (15 000 households), and all persons in the selected households were eligible for the survey. Additional details of the survey methodology, including fieldwork procedures and quality control measures, are described elsewhere. [19] Dried blood spot specimens collected by finger prick were tested in a laboratory for HIV antibodies using a testing algorithm with three different immunoassays. All HIV testing was anonymous and unlinked to personal identifiers. Individuals were given an opportunity to access their HIV test results 8 weeks after testing at designated facilities, using bar codes to preserve anonymity. The study protocol was approved by the Human Sciences Research Council's Research Ethics Committee (ref. no. 5/17/11/10) and the Human Subjects Review from the Centers for Disease Control and Prevention's Global AIDS Programme. Only women in the reproductive age group (15 -49 years) who had ever had sex were included in this analysis.
Study measures
Data were drawn from face-to-face questionnaires, which elicited detailed information on demographic and socioeconomic characteristics, contraception use, sexual behaviours and other risk factors for HIV infection. In a multiple-response question, women were asked if they ever had used or were currently using a contraceptive method, specifically injectable or oral contraception, an intrauterine device (IUD), female or male sterilisation, or natural family planning. In a separate question, women reported condom use at last sex and consistent condom use with their last partner. Injectable contraception referred to the use of either DMPA or NET-EN, as women were not asked to differentiate between these methods.
Contraceptive prevalence was defined as the percentage of women aged 15 -49 years, who were using (or whose partner was using) a contraceptive method at the time of the interview. [20] Contraceptive methods consisted of injectable and oral hormones, IUDs, female and male sterilisation, emergency contraception, and other (consistent condom use with last partner, natural family planning, or withdrawal). The indicator only includes women who were sexually active (had sex in previous 12 months), and not pregnant or amenorrhoeic. Injectable and oral hormones, IUDs, and female or male sterilisation were considered modern contraception. Condoms were excluded from this definition as biases inherent in its measurement may both under-and overestimate its use for contraception, hampering interpretation. [21] We used unintended pregnancy as a proxy indicator of unmet need for contraception.
Socioeconomic quartiles were derived from measures of household living standards captured in the household questionnaire: infrastructure and housing characteristics (source of drinking water, access to electricity, main source of energy for cooking and type of toilet used) and household ownership of durable assets (presence of a working refrigerator, radio, television, cellphone and landline phone). Details of how quartiles were generated and the rationale for using quartiles, rather than the commonly used quintiles, are provided elsewhere. [22, 23] 
Data management and analysis
After double data entry, data validity was verified using the Census and Survey Processing System (CSPro) (US Census Bureau, USA). [24] Data were analysed using Stata version 14.0 (Stata Corporation, USA), taking into account the complex multilevel sampling design (by age, race group and province) and participant non-response. Summary indices for descriptive analysis are weighted percentages, and unweighted counts are provided.
Descriptive analyses were conducted to investigate whether use of any contraception or individual method was associated with demographic, social or economic characteristics, or pregnancy history. We also determined whether sexual behaviour, condom use, HIV risk perception and HIV status varied between women using different contraceptive methods. In descriptive and bivariate analyses, associations were identified using the Rao-Scott F statistic to determine p-values.
Results
Unmet need for contraception
Among the 8 482 women aged 15 -49 years who had ever had sex, 81.1% reported being sexually active in the past year (Table 1) . These figures were lowest among women 35 -49 years (75.1%) compared with 83.0% in those 15 -19 years, and about 85% among the other age groups (p<0.001). Age was also associated with unintended pregnancy among the 3 538 women who reported a pregnancy in the past 5 years. Overall, a third of these women (33.5%) had desired to become pregnant at the time of their last pregnancy; this was reported by only 10.1% of women 15 -19 years of age and 20.9% of those 20 -24 years of age (p<0.001). At the time of the pregnancy, about half of women 15 -19 years (51.2%) and 20 -24 years (48.5%) had not wanted to have a child. In older women, these levels were 41.3% for women 25 -34 years and 44.9% for those 35 -49 years. Among the 276 women who were pregnant at the time of the survey, only half (50.6%) had wanted to become pregnant. About a quarter (24.0%) of all women who reported a pregnancy in the past 5 years had been using a contraceptive method at the time of their pregnancy. These levels were only 12.8% in 15 -19-year-olds compared with 19.7% in 20 -24-year olds and 26.1% in women ≥25 years (p<0.01).
Contraceptive knowledge and prevalence
Of women who had ever had sex, almost all (92.0%) were aware of injectable contraception, with similarly high levels of knowledge of oral contraception (89.9%) and female sterilisation (73.3%; Table 2 ). Only about half, however, had heard of IUDs, emergency contraception or male sterilisation (56.1%, 47.3%, and 45.3%, respectively). Levels of knowledge among women aged 15 -19 years were lower than those of older women for each contraceptive method. Most notably, only 30.9% of 15 -19-year-olds knew of IUDs and 36.2% of emergency contraception, considerably lower than for other women. On average, women had heard of 4 -5 contraceptive methods in total.
Just under half of the 8 245 women responding to questions about lifetime contraception use (women who had ever had sex) reported having ever used injectable contraception (46.2%) and a quarter had ever used oral contraception (25.6%). Aside from the 'other contra-RESEARCH ceptive' category, ever use of all other methods (IUD, female sterilisation, male sterilisation, and emergency contraception) was <10%. Overall, current contraceptive prevalence was 49.1%, and 41.8% of women were using modern, non-barrier methods (Table 3) . Injectable contraception was by far the most common method, used by 25.0% of women. Other methods were several-fold less common and only a negligible portion were using an IUD (1.6%). Among injectable contraception users, the majority had obtained this method of contraception at a clinic or community health centre (70.8%), while other methods were much less likely to have been provided at these facilities (<50% for all). A notably higher proportion of oral and emergency contraception users, and female and male sterilisation users, acquired their contraception from a private facility or doctor (23.0%, 21.3%, 26.5% and 41.5% respectively), while a considerable proportion of IUDs were obtained from a pharmacy (27.3%). Table 3 shows the distribution of contraceptive methods among the 6 296 sexually active women, stratified by sociodemographic groups. Only about a third of women aged 15 -19 years were using modern contraception, only 5.0% were using oral contraception, and 0.4% an IUD. Compared with their younger counterparts, more women aged 20 -34 or 35 -49 years were using modern contraception (42.7% and 41.8%, respectively). A considerable proportion of women 35 -49 years old had been sterilised (16.4%), but their use of injectables (16.2%) was much lower than that of women aged 15 -19 years (26.1%) and those 20 -34 years (30.5%).
Sociodemographic factors and contraception use
Contraceptive coverage was highest in the Western Cape (54.0%), Eastern Cape (50.7%) and KwaZulu-Natal (50.1%), and lowest in the Northern Cape (42.2%) and Mpumalanga (45.0%). Prevalence of any contraceptive use differed by race, ranging from 47.2% in black Africans, 52.4% in coloureds, 61.1% in Indians/Asians, to 61.9% in whites (p<0.001). While 27.5% of black African and 23.8% of coloured women were using injectables, the method is only used by 6.8% of Indians/Asians, and 4.8% of whites (p<0.001). Oral contraception, on the other hand, was more likely to be reported by white and Indian/Asian women (22.8% and 22.5%, respectively). IUDs were also relatively more common among whites (6.0%) and Indians/Asians (3.8%). Female sterilisation among Indian/Asian RESEARCH women (27.9%) was considerably more frequent than in other races, while 16.6% of white women had been sterilised, as had 13.0% of their male partners. Compared with the poorest quartile, women in the two highest socioeconomic quartiles were much less likely to use injectable hormonal contraceptives (for QIII: odds ratio (OR) 0.60, 95% confidence interval (CI) 0.46 -0.78; and for QIV: OR 0.30, 95% CI 0.22 -0.41). However, the opposite associations were observed with all other contraceptive methods, higher socioeconomic quartiles being associated with increased odds of contraceptive use. Associations between educational level and contraceptive method mirrored those of socioeconomic status (SES). For example, the method mix for women with tertiary education differed considerably from others: 14.5% were using oral contraception and 2.4% had used emergency contraception -much higher than in other groups. Table 4 shows the distribution of sexual behaviour by contraceptive method. Overall, of all sexually active women, most reported ≤3 lifetime sexual partners (75.0%), and only 5.3% had had >1 partner over the past year. Close to 40.0% of participants mentioned having had age-disparate sex partners (partners ≥5 years older than the woman). About a third used a condom at last sex (38.5%) and reported consistent condom 
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001).
One-third of sexually active women perceived themselves to be at high risk of HIV infection (34.6%). Perceptions of risk for HIV varied by race and contraceptive method. Perceptions of high risk were markedly higher among black Africans than other race groups. Some 46.2% of black African women currently using injectables felt they were at high risk for HIV infection, higher than levels among black Africans using oral contraceptives (38.6%) and sterilisation (30.7%), or those not using any methods (38.3%). Less than 5% of white, coloured or Indian/Asian women perceived themselves at risk for HIV, with similar levels between women using different contraceptive methods. Interestingly, perceptions of HIV risk were high among women who used emergency contraception (43.1%), but they also reported high levels of consistent condom use (47.2%). HIV-positive women were less likely than HIV-negative women to use oral contraception, IUDs or to have been sterilised. Use of injectables did not vary by HIV status.
Discussion
In this national survey of women, about 41.0% were using modern contraception. Gradual increments have been made in contraception prevalence over time in SA, although the rate of increase appears RESEARCH to be slowing. Consistent with rises in contraception use, the total fertility rate has declined gradually, from 2.7 children per woman in 2002 to 2.3 in 2013. [25] The fastest rate of change in fertility occurred in the Eastern Cape and KwaZulu-Natal, provinces with among the highest levels of contraceptive prevalence in this study. Of note, we found that about two-thirds of all pregnancies were unintended, similar to levels reported in several smaller studies. [26] [27] [28] The rate of unintended pregnancy was even higher in young women, who commonly experience stigma and economic difficulties during pregnancy, [29] and especially high levels of maternal morbidity and mortality. [30] [31] [32] Low levels of knowledge and frequent misconceptions about contraception among women of 15 -19 years are particularly concerning. [33, 34] These findings cast doubt on how effectively the national Integrated School Health Policy [35, 36] is being implemented. The policy recommends that school health services act as a delivery platform for the provision of sexual and reproductive health services, such as contraception and condom distribution. [37] Legally, anyone aged ≥12 years has the right to receive contraception without parental consent. [38] The provision of contraception in schools, however, requires the explicit permission of individual school-governing bodies -few have, however, given permission. [39] When contraception services are made available, school-based services will need to be carefully designed to counter adolescents' concerns around privacy, [35] as also noted in studies of HIV testing in schools. [40] Youth-friendly services in community-based primary care facilities are another important option for improving adolescent access to contraception. Over the past two decades, many initiatives have been made in this direction in SA. [36, 41] These programmes reached high coverage and performed well against predefined standards relating to services provided and clinical environment. [42, 43] In recent years, however, several reports have noted weaknesses in these programmes and the need for strengthening of these services. [36, 43, 44] In the public sector, more broadly, supply-side barriers include strong provider preferences for particular methods, lengthy waits at clinic services, and staff with negative attitudes, e.g. towards young women requesting contraception or an abortion. [45] Although, overall, women largely make use of the public sector for healthcare, [46] a large proportion of women in our study turned to private sector doctors or pharmacists, where they are offered a wider mix of methods. This suggests that the government's policy, that women requesting contraception should receive the method of their choice, has not been fully actualised, especially in primary health clinics and community centres. Contraception use and method type are strongly associated with race in this study and also with SES at an individual and geographical level. Marked differentials between poor and wealthy districts were noted in other studies. [47] [48] [49] All the abovementioned reasons relating to age and SES mean that younger poorer women are particularly vulnerable to unintended pregnancies, and much remains to be done to mitigate their risk. [33, 49, 50] The National Contraception and Fertility Planning Policy and Service Delivery Guidelines [51] in 2012 marked an important step away from methods requiring users' adherence, and placed particular emphasis on LARC methods, aiming to raise choice and contraceptive effectiveness (a quarter of women who had a pregnancy reported contraceptive failure in our study). The guidelines state that clients should have access to 'accurate, unbiased information about all available methods to make an informed choice' . In practice, what is available in primary level facilities varies and coverage of services for sterilisation, and even IUD insertion, is extremely limited in some districts. [36] Facilities such as those for HIV treatment seldom offer contraceptive services. Ensuring adequate stocks of the wide range of contraceptive methods is contingent on accurate forecasting of the demand for each method. This is difficult to achieve, given the limited data available in the public sector to predict the anticipated demand, especially for new methods. [36] With injectable contraception, which comprises three-quarters of the modern methods used, method discontinuation, timeliness of repeat injections, and switching remain key contributors to contraception failures in SA. [17, 18, 21] Up to half of women in a study in the Eastern and Western Cape were late for their re-injection appointment. [18] Women, however, have limited knowledge of and experience with the 'newer' contraceptive methods. [26, 33, 34, 52, 53] Only half of our participants had heard of emergency contraception, the same portion as a study among female university students in 2011, [54] but higher than the 30.0% knowledge found in a Cape Town study of women in public sector clinics in 2004/2005. [53] Clearly, the introduction of LARCs and future multipurpose technologies will require intensive awareness campaigns, encompassing efforts to address health worker misperceptions of these technologies. [10, 11] Encouragingly, despite these problems, uptake of sub-dermal implants, rolled out in 2014 in SA and accompanied by substantial promotion efforts, has been encouraging. [55] Training manuals covering implant insertion were developed and >6 000 providers were trained, mainly nurses. While as many as 800 000 devices had been inserted by the end of 2014, [56] the delivery of the method has been hampered by poor data for monitoring adverse effects, such as early removal of the device, and poor communication by the National Department of Health around concerns of drug interactions between the antiretroviral drug efavirenz and the synthetic progesterones in the implant. [36] Injectable contraception, particularly DMPA, has been associated with an increased risk of HIV acquisition in some, but not all, studies. [57, 58] Overall, systematic reviews and an individual patient data meta-analysis suggest about a 1.5-fold increased risk of HIV acquisition with DMPA exposure, [59, 60] but many studies included in these reviews have important methodological flaws. [61] After many years of calls for a randomised controlled trial to deeply examine this relationship, a trial will commence shortly. [62, 63] Until further data are available, it is likely that the benefits of discouraging DMPA use would be outweighed by the risks of unwanted pregnancy and maternal deaths. This is especially true of countries such as Madagascar, with high maternal mortality risks, [64] but perhaps less so in SA. In our study, HIV-positive women were less likely than HIVnegative women to use oral contraception and IUDs. Some evidence indicates that many health workers hold misconceptions about interactions between contraception and antiretroviral treatment, and offer HIV-positive women different contraceptives than other women. [10, 26, [65] [66] [67] [68] Other studies, however, have found that HIVpositive and HIV-negative women have a similar methods mix and fertility goals. [26, 65, [68] [69] [70] Integration of family planning within services for antiretroviral treatment and for prevention of motherto-child transmission holds much promise in raising contraceptive prevalence among HIV-positive women, [1, 27, 71] although it is not without challenges. [72] 
Study limitations
This article provides population-level representative data for the country, a uniquely important dataset. However, cross-sectional studies such as this one do not allow for observation of temporal relationships. This study cannot ascertain which contraceptive method was used at the time of HIV acquisition and thus cannot investigate causal associations between HIV infection and contraception method, for example. Additional limitations include a reliance on self-reporting of contraceptive use. It was therefore not possible to assess methods RESEARCH dispensed, but not actually used, or used incorrectly (especially user-dependent methods such as oral contraception and condoms). [73] Finally, while the study provides some measure of unmet need for contraception, this indicator is hard to measure, and the variable used (unintended pregnancy) only provides limited information. [74, 75] 
Conclusion
Even though levels appear to be rising slowly over time, less than half of SA women were using a modern contraceptive method in 2012. Women with only primary school education and of lower SES were less likely to report contraceptive use. In light of high unintended pregnancy rates and contraceptive failure noted in this study, it is hoped that SA's new contraceptive policy and clinical guidelines [51, 76] will be fully implemented as a national health priority. Additional emphasis on access to LARCs, particularly among women in poorer provinces and with lower SES, is necessary in the coming years to further improve the SA family planning services. Until then, injectable contraception remains an important contraceptive method for women in this country, particularly for black African women and those with lower SES, who do not yet have access to a range of methods. In common with other countries, [77] young women had low contraception use and poorer levels of knowledge about these methods, making it clear that the reproductive health component of the School Health Programme needs to be considerably strengthened. It is very disappointing that many young women leave school with little knowledge of contraception. In summary, access to contraception and choice of a range of methods are key interventions to improve population health, particularly that of women. Increased political and economic investment is necessary to decrease disparities in access to contraception between population groups and to raise overall levels of contraception.
